DexCom (NASDAQ:DXCM) PT Raised to $153.00 : vimarsana.com

DexCom (NASDAQ:DXCM – Get Free Report) had its price objective boosted by analysts at Robert W. Baird from $145.00 to $153.00 in a report issued on Friday, FlyOnTheWall reports. Robert W. Baird’s target price indicates a potential upside of 15.58% from the stock’s current price. Several other research analysts have also recently issued reports on […]

Related Keywords

United States , China , Raymond James , Robertw Baird , Stifel Nicolaus , Steven Robert Pacelli , Australiansuper Pty Ltd , China Universal Asset Management Co , Citigroup , Traynor Capital Management Inc , Jackson Square Capital , Vanguard Personalized Indexing Management , Dexcom Company Profile , Morgan Stanley , Securities Exchange Commission , Dexcom Inc , Get Free Report , Director Steven Robert Pacelli , Exchange Commission , Super Pty Ltd , Capital Management , Personalized Indexing Management , Square Capital , China Universal Asset Management , Universal Asset Management , Dexcom Share , Dexcom Real Time , Dexcom Daily , Dexcom , Nasdaq Dxcm , Dxcm , Medical , 25213110 , Boost Price Target ,